Compare Novartis with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs SUVEN LIFESCIENCES - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS SUVEN LIFESCIENCES NOVARTIS/
SUVEN LIFESCIENCES
 
P/E (TTM) x 890.4 2.3 39,187.9% View Chart
P/BV x 26.8 0.5 5,074.6% View Chart
Dividend Yield % 1.7 4.4 37.9%  

Financials

 NOVARTIS   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    NOVARTIS
Mar-19
SUVEN LIFESCIENCES
Mar-19
NOVARTIS/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs980338 290.2%   
Low Rs600169 354.3%   
Sales per share (Unadj.) Rs198.752.1 381.2%  
Earnings per share (Unadj.) Rs21.06.8 307.0%  
Cash flow per share (Unadj.) Rs22.38.6 259.7%  
Dividends per share (Unadj.) Rs10.001.50 666.7%  
Dividend yield (eoy) %1.30.6 213.9%  
Book value per share (Unadj.) Rs307.565.3 471.0%  
Shares outstanding (eoy) m24.69127.28 19.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.04.9 81.7%   
Avg P/E ratio x37.737.1 101.5%  
P/CF ratio (eoy) x35.529.6 120.0%  
Price / Book Value ratio x2.63.9 66.2%  
Dividend payout %47.722.0 217.2%   
Avg Mkt Cap Rs m19,50832,272 60.4%   
No. of employees `0000.61.1 53.7%   
Total wages/salary Rs m1,171661 177.1%   
Avg. sales/employee Rs Th8,445.46,132.2 137.7%   
Avg. wages/employee Rs Th2,015.7611.1 329.8%   
Avg. net profit/employee Rs Th891.0803.5 110.9%   
INCOME DATA
Net Sales Rs m4,9076,635 74.0%  
Other income Rs m783242 323.0%   
Total revenues Rs m5,6896,877 82.7%   
Gross profit Rs m1231,604 7.7%  
Depreciation Rs m32221 14.4%   
Interest Rs m1638 42.2%   
Profit before tax Rs m8581,587 54.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m340718 47.4%   
Profit after tax Rs m518869 59.5%  
Gross profit margin %2.524.2 10.4%  
Effective tax rate %39.645.2 87.6%   
Net profit margin %10.613.1 80.5%  
BALANCE SHEET DATA
Current assets Rs m8,0556,232 129.2%   
Current liabilities Rs m1,8501,490 124.2%   
Net working cap to sales %126.471.5 176.9%  
Current ratio x4.44.2 104.1%  
Inventory Days Days4586 52.1%  
Debtors Days Days3483 41.1%  
Net fixed assets Rs m1504,043 3.7%   
Share capital Rs m123127 96.9%   
"Free" reserves Rs m7,4698,183 91.3%   
Net worth Rs m7,5928,310 91.4%   
Long term debt Rs m018 0.0%   
Total assets Rs m9,82410,389 94.6%  
Interest coverage x54.943.1 127.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.6 78.2%   
Return on assets %5.48.7 62.2%  
Return on equity %6.810.5 65.2%  
Return on capital %11.519.5 59.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m585,622 1.0%   
Fx outflow Rs m1,3261,799 73.7%   
Net fx Rs m-1,2693,822 -33.2%   
CASH FLOW
From Operations Rs m-1,943356 -546.5%  
From Investments Rs m2,742-279 -984.3%  
From Financial Activity Rs m-298-225 132.5%  
Net Cashflow Rs m501-148 -338.3%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 0.0 -  
FIIs % 1.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 36.5 58.9%  
Shareholders   41,647 37,287 111.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   BIOCON   CADILA HEALTHCARE  VENUS REMEDIES  PANACEA BIOTECH  WOCKHARDT  

Compare NOVARTIS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Metal and Telecom Stocks Lead(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.3% while the Hang Seng is down 0.3%.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World(Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade?(Profit Hunter)

May 25, 2020

Will the mutlibagger blue chips of the past decade continue to rule the bourses?

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jun 4, 2020 10:47 AM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS